200,000+ products from a single source!
sales@angenechem.com
250601-04-8 | Benzenebutanoic acid, γ-[[[4-[(5-methyl-2-phenyl-4-oxazolyl)methoxy]phenyl]methoxy]imino]-, (γE)-
CAS No: 250601-04-8 Catalog No: AG002QBE MDL No:
Product Description
Catalog Number:
AG002QBE
Chemical Name:
Benzenebutanoic acid, γ-[[[4-[(5-methyl-2-phenyl-4-oxazolyl)methoxy]phenyl]methoxy]imino]-, (γE)-
CAS Number:
250601-04-8
Molecular Formula:
C28H26N2O5
Molecular Weight:
470.5164
IUPAC Name:
4-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]methoxyimino]-4-phenylbutanoic acid
InChI:
InChI=1S/C28H26N2O5/c1-20-26(29-28(35-20)23-10-6-3-7-11-23)19-33-24-14-12-21(13-15-24)18-34-30-25(16-17-27(31)32)22-8-4-2-5-9-22/h2-15H,16-19H2,1H3,(H,31,32)
InChI Key:
ULVDFHLHKNJICZ-UHFFFAOYSA-N
SMILES:
OC(=O)CC/C(=N\OCc1ccc(cc1)OCc1nc(oc1C)c1ccccc1)/c1ccccc1
Properties
Complexity:
666
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
470.184g/mol
Formal Charge:
0
Heavy Atom Count:
35
Hydrogen Bond Acceptor Count:
7
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
470.525g/mol
Monoisotopic Mass:
470.184g/mol
Rotatable Bond Count:
11
Topological Polar Surface Area:
94.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
1
XLogP3:
5.1
Literature
| Title | Journal |
|---|---|
| Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators. | The open medicinal chemistry journal 20110101 |
| Should We Use PPAR Agonists to Reduce Cardiovascular Risk? | PPAR research 20080101 |
| Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists. | PPAR research 20080101 |
| A novel peroxisome proliferator--activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys. | Metabolism: clinical and experimental 20071001 |
| Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target. | Antimicrobial agents and chemotherapy 20060401 |
| A potent activator of PPARalpha and gamma reduces the vascular cell recruitment and inhibits the intimal thickning in hypercholesterolemic rabbits. | Atherosclerosis 20050101 |
| A novel oxyiminoalkanoic acid derivative, TAK-559, activates human peroxisome proliferator-activated receptor subtypes. | European journal of pharmacology 20040708 |
| In vitro antimicrobial activity of T-91825, a novel anti-MRSA cephalosporin, and in vivo anti-MRSA activity of its prodrug, TAK-599. | Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20040601 |
| Studies on non-thiazolidinedione antidiabetic agents. 3. Preparation and biological activity of the metabolites of TAK-559. | Chemical & pharmaceutical bulletin 20040101 |
| Studies on non-thiazolidinedione antidiabetic agents. 2. Novel oxyiminoalkanoic acid derivatives as potent glucose and lipid lowering agents. | Chemical & pharmaceutical bulletin 20030201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.